Unique ID issued by UMIN | UMIN000030710 |
---|---|
Receipt number | R000034911 |
Scientific Title | Study on the variables related to blood glucose control and safety of long-term ingestion of sterile packaged cooked rice. |
Date of disclosure of the study information | 2018/01/10 |
Last modified on | 2021/12/13 14:07:33 |
Study on the variables related to blood glucose control and safety of long-term ingestion of sterile packaged cooked rice.
Study on the variables related to blood glucose control and safety of long-term ingestion of sterile packaged cooked rice.
Study on the variables related to blood glucose control and safety of long-term ingestion of sterile packaged cooked rice.
Study on the variables related to blood glucose control and safety of long-term ingestion of sterile packaged cooked rice.
Japan |
Healthy volunteers
Adult |
Others
NO
Evaluation of blood glucose suppression effects and safety of long-term ingestion of packaged cooked rice with black rice or with barley.
Evaluation of suppressive effects of amyloid beta and advanced glycation end products (AGE) .
Safety,Efficacy
Variables related to blood glucose control (blood glucose level, inslin, HOMA-IR, IAUCg, IAUCi (0-120min)) , safety
Amyloid beta, HbA1c, AGE, Acceptability
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Placebo
3
Prevention
Food |
Test food -1 :12-week intake of packaged rice cooked with black brown rice (40%), super-hard rice (40%), and koshihikari brown rice (20%), followed by high pressure treatment (200MPa).
Test food -2 : 12week intake of packaged rice cooked with koshihikari (50%) and barley (50%), followed by high pressure treatment (200MPa).
Pracebo food : 12-week intake of koshihikari packaged cooked rice .
20 | years-old | <= |
75 | years-old | > |
Male and Female
1.Volunteers of higher IAUC responders to white rice in healthy subjects, by finger - prick blood measurement at 0 (pre intake), 15, 30, 45, 60, 90 and 120min post intake of white rice.
2.Fasting plasma glucose = <140mg/dL.
3.Volunteer having screening test result and questionnaire result judged to be appropriate for this study by investigator.
1.Diabetes under medical treatment.
2.Volunteers having severe diseases (e.g. liver, kindney, heart, blood diseases, and infections requiring the notification)
3.Volunteers received gastrectomy, enterectomy, and gastro-intestinal diseases, juded to be inappropriate for this study.
4.Pregnant, women having the possibility, and lactating women.
5.Volunteers rejected participating in this study by chief investigator.
36
1st name | Kenichi |
Middle name | |
Last name | Watanabe |
Niigata Bio-Research Park, Inc
Advisor
956-0841
316-2 Higashijima, Akiha-ku, Niigata, 956-0841, Japan
0250-25-1196
wataken@med.niigata-u.ac.jp
1st name | Hiroshi |
Middle name | |
Last name | Goto |
Niigata Bio-Research Park, Inc
Business promotion division
956-0841
316-2 Higashijima, Akiha-ku, Niigata, 956-0841, Japan
0250-25-1196
goto@nbrp.co.jp
Niigata Bio-Research Park , Inc
Niigata University of Phamacy and Applied Life Sciences , Faculty of Applied Life Sciences.
Other
Niigata Bio-Research Park , Inc
316-2 Higasijima, Akiha-ku, Niigata, 956-0841, Japan
0250-25-1196
nbrp-food-navi@nbrp.co.jp
NO
2018 | Year | 01 | Month | 10 | Day |
Unpublished
Completed
2017 | Year | 11 | Month | 08 | Day |
2018 | Year | 01 | Month | 10 | Day |
2018 | Year | 01 | Month | 06 | Day |
2021 | Year | 12 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034911